Purpose
to produce more poliovirus vaccine supply while reducing production costs by silencing non-essential virus resistance genes to develop enhanced vaccine cell lines
Grantee
Division
Global Development
Date
OCTOBER 2011
Region served
GLOBAL
Committed amount
$222,411
Grant topic
Polio
Duration (months)
17
Grantee location
Athens, Georgia, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.